TY  - GEN
AU  - Ringdén,O
AU  - Remberger,M
AU  - Svenberg,P
AU  - Svahn,B-M
AU  - Dahllöf,G
AU  - Gustafsson,B
AU  - Hassan,Z
AU  - Omazic,B
AU  - Uzunel,M
AU  - Aschan,J
AU  - Barkholt,L
AU  - Winiarski,J
AU  - Ljungman,P
AU  - Mattsson,J
TI  - Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
SN  - 0268-3369
PY  - 2007///0516
KW  - Adolescent
KW  - Adult
KW  - Anemia, Aplastic
KW  - therapy
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Hemoglobinopathies
KW  - Humans
KW  - Immunologic Deficiency Syndromes
KW  - Infant
KW  - Male
KW  - Middle Aged
KW  - Transplantation Conditioning
KW  - Vidarabine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bmt.1705602
ER  -